Amgen Faces Data Breach Amid Surge in Cyberattacks on Healthcare Firms
Pharmaceutical giant Amgen has disclosed a data breach involving patient health information and company data. The incident occurred on July 29 when hackers stole data from cloud storage systems managed by third-party providers.
The company determined that the incident was material due to the large number of files affected and the possibility of sensitive information being accessed or stolen.
Amgen has activated its cybersecurity response plan, put containment measures in place, and brought in independent forensic experts to investigate. The company is assessing whether patient data, confidential business information, intellectual property, research, and development were compromised.
To date, Amgen has not found any impact on its products, manufacturing operations, financial reporting systems, or ability to meet patient needs.